Comparability of biotechnology-derived medicinal products after a change in the manufacturing process - non-clinical and clinical issues

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CHMP/BMWP/101695/2006
Effective from01/11/2007
KeywordsComparability testing, changes in manufacturing procedure, non-clinical, efficacy, pharmacovigilance
DescriptionThis document gives advice on the non-clinical and clinical requirements of the comparability exercise comparing post-change product to pre-change product where manufacturing process changes are made by a single manufacturer, including those made by a contract manufacture. It addresses the requirements for non-clinical and/or clinical bridging studies to demonstrate that the manufacturing change has no impact on safety and efficacy.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/11/2007–present

Published: 24/01/2007

Published: 22/02/2006

Superseded document

PDF iconAdopted guideline

PDF iconConcept paper

In operation: 01/06/2004–31/10/2007

Published: 24/06/1998

Related content

How useful was this page?

Add your rating
1 rating